Literature DB >> 18704952

A particle rearrangement index based on the Kawakita powder compression equation.

J Nordström1, I Klevan, G Alderborn.   

Abstract

In this article, the effect of original particle size on the Kawakita parameters, denoted a and b, has been studied using four model materials of different compression mechanics. It was found that fine powders, possibly showing significant particle rearrangement at low compression pressures, showed low values of parameter b(-1) and high values of parameter a. It is thus proposed that the product of these parameters is an indication of the overall contribution of particle rearrangement to the compression profile. Above a critical original particle size of a powder, particle rearrangement is negligible for the overall compression profile and below this critical particle size, particle rearrangement becomes significant. A critical particle size of about 40 microm was obtained. A classification of powders into groups dependent on the incidence of particle rearrangement is discussed and it is suggested that a rearrangement index and a classification system could be used as tools to enable rational interpretations of global compression parameters. (c) 2008 Wiley-Liss, Inc. and the American Pharmacists Association

Mesh:

Substances:

Year:  2009        PMID: 18704952     DOI: 10.1002/jps.21488

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Preparation and characterization of a novel co-processed excipient of chitin and crystalline mannitol.

Authors:  Nidal Daraghmeh; Iyad Rashid; Mahmoud M H Al Omari; Stephen A Leharne; Babur Z Chowdhry; Adnan Badwan
Journal:  AAPS PharmSciTech       Date:  2010-11-04       Impact factor: 3.246

Review 2.  Chitin and chitosan as direct compression excipients in pharmaceutical applications.

Authors:  Adnan A Badwan; Iyad Rashid; Mahmoud M H Al Omari; Fouad H Darras
Journal:  Mar Drugs       Date:  2015-03-19       Impact factor: 5.118

3.  Co-processed chitin-mannitol as a new excipient for Oro-dispersible tablets.

Authors:  Nidal Daraghmeh; Babur Z Chowdhry; Stephen A Leharne; Mahmoud M H Al Omari; Adnan A Badwan
Journal:  Mar Drugs       Date:  2015-03-30       Impact factor: 5.118

4.  Lignin and Cellulose Blends as Pharmaceutical Excipient for Tablet Manufacturing via Direct Compression.

Authors:  Juan Domínguez-Robles; Sarah A Stewart; Andreas Rendl; Zoilo González; Ryan F Donnelly; Eneko Larrañeta
Journal:  Biomolecules       Date:  2019-08-28

5.  Understanding the Performance of a Novel Direct Compression Excipient Comprising Roller Compacted Chitin.

Authors:  Deeb Abu Fara; Linda Al-Hmoud; Iyad Rashid; Babur Z Chowdhry; Adnan Badwan
Journal:  Mar Drugs       Date:  2020-02-17       Impact factor: 5.118

6.  A Direct Compression Matrix Made from Xanthan Gum and Low Molecular Weight Chitosan Designed to Improve Compressibility in Controlled Release Tablets.

Authors:  Deeb Abu Fara; Suha M Dadou; Iyad Rashid; Riman Al-Obeidi; Milan D Antonijevic; Babur Z Chowdhry; Adnan Badwan
Journal:  Pharmaceutics       Date:  2019-11-12       Impact factor: 6.321

7.  Hydrochlorothiazide/Losartan Potassium Tablet Prepared by Direct Compression.

Authors:  Qiuhua Luo; Qianying Zhang; Puxiu Wang
Journal:  Pharmaceutics       Date:  2022-08-21       Impact factor: 6.525

8.  Evaluation of Lactose-Based Direct Tableting Agents' Compressibility Behavior Using a Compaction Simulator.

Authors:  Yıldız Özalp; Motunrayo M Onayo; Nailla Jiwa
Journal:  Turk J Pharm Sci       Date:  2020-08-28

9.  Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration.

Authors:  Kevin Garala; Jaydeep Patel; Anjali Patel; Mihir Raval; Abhay Dharamsi
Journal:  Int J Pharm Investig       Date:  2012-10

10.  Influence of Chitin Source and Polymorphism on Powder Compression and Compaction: Application in Drug Delivery.

Authors:  Linda Al-Hmoud; Deeb Abu Fara; Iyad Rashid; Babur Z Chowdhry; Adnan A Badwan
Journal:  Molecules       Date:  2020-11-12       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.